Cytogenetic abnormalities without evidence of relapse after treatment with imatinib and stem cell transplantation in a patient with Ph-positive ALL

Int J Hematol. 2005 Feb;81(2):171-3. doi: 10.1532/ijh97.04179.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Benzamides
  • Chromosome Aberrations / chemically induced*
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Imatinib Mesylate
  • Middle Aged
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use
  • Remission Induction / methods
  • Transplantation Chimera

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate